Interview: Virtual Reality, Machine Learning and Biosensing Advances Converging to Transform Healthcare and Beyond


Date:  Wednesday, May 21

Start Time: 4:50 pm

End Time: 5:55 pm

In this wide-ranging interview, neuroscientist and product developer Walter Greenleaf will explain how advances in virtual and augmented reality, machine learning and agentic AI and biosensing and embedded vision are converging to transform not only healthcare but human interaction as well. He will detail how this convergence will impact clinical care, disability solutions and personal health and wellness. Through real-time monitoring of physiological measurements, eye movements, voice tone, facial expressions and behavioral patterns, these integrated technologies are enabling sophisticated systems capable of sensing, analyzing and adapting to our arousal levels, cognitive status and emotional state, adjusting to individual preferences and interaction styles. Walter will examine how this technological revolution will transform physical and mental health as well as how humans interact with each other and with the world around us. Join us to learn how agentic AI and immersive visualization will unleash truly personalized experiences that reflect and enhance an individual’s physical and mental health.

Track

Session Speakers

  • Thomas Vogelsong, PhD, is an angel investor and advisor to innovative start-ups in tech, medtech and biotech. Tom scouts investment prospects for K2X, an organization of over 250 angel investors that has invested as a group in 88 start-ups over the past six years. Tom'’s degrees are in Electrical Engineering and Semiconductor Physics. He has specialized in imaging and image processing in medical, industrial, consumer, space and defense applications. Tom was CEO of Photon Vision Systems, a pioneer in CMOS image sensors, cameras and applications. Tom is also a Senior Consultant for BioPharma Connections and has been a speaker, judge, panelist and session chair for many events, including the Embedded Vision Summit. Tom enjoys tennis, pickleball, skiing and traveling in his spare time.

  • Walter Greenleaf, PhD, is a Neuroscientist and Medical Technology Developer at Stanford University. With over 35 years of experience in medical research and product development, he is a leading authority in digital medicine and the clinical application of virtual reality technology. Walter has developed systems that address a wide range of conditions, including post-traumatic stress disorder, anxiety disorders, stroke, addictions, autism spectrum disorder, depression, neurodegenerative diseases and traumatic brain injury as well as neurorehabilitation and other complex challenges in healthcare. He serves as an advisor to the Stanford Virtual Human Interaction Lab, the Stanford Wearable Electronics Initiative and the Virtual Reality and Immersive Technology Clinic at Stanford. Walter was the founding Chief Science Officer for Pear Therapeutics and currently holds the position of Chief Science Officer at Interaxon. In addition to his research at Stanford, he is a technology and neuroscience advisor for several medical product development companies and investment groups.


Share

Interview: Virtual Reality, Machine Learning and Biosensing Advances Converging to Transform Healthcare and Beyond